(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 46.64% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Ideaya Biosciences's revenue in 2024 is $23,385,000.On average, 6 Wall Street analysts forecast IDYA's revenue for 2024 to be $1,640,326,006, with the lowest IDYA revenue forecast at $521,921,911, and the highest IDYA revenue forecast at $2,385,928,736. On average, 4 Wall Street analysts forecast IDYA's revenue for 2025 to be $2,495,532,337, with the lowest IDYA revenue forecast at $1,491,205,460, and the highest IDYA revenue forecast at $4,285,724,492.
In 2026, IDYA is forecast to generate $5,866,402,280 in revenue, with the lowest revenue forecast at $1,920,672,632 and the highest revenue forecast at $11,759,646,258.